Pronukleotydy o strukturze amidofosforanów i ich wewnątrzkomórkowy mechanizm aktywacji Phosphoramidate pronucleotides and their intracellular activation mechanism
Nucleoside analogues have great therapeutic potential for the treatment of cancer
and viral diseases. Once inside the cell, they are activated by a series of intracellular
phosphorylation steps to produce 5’-triphosphate derivatives, which can be
incorporated to DNA or RNA and act as terminators of growing polynucleotide
chains [1c]. In many cases, nucleoside analogues are poor substrates for the cellular
kinases needed for their activation [5]. It is clear that intracellular introduction
of nucleoside analogues as phosphorylated metabolites (so called pronucleotides)
could circumvent difficulties associated with the use of non-phosphorylated nucleoside
analogues and could even activate inactive compounds or could increase
the activity of the nucleoside analogues. However, polarity and a ready degradation
by phosphatases make the use of free nucleotide analogues impractical. Therefore,
much of the recent efforts have been focused on finding suitable prodrugs of nucleoside
analogue monophosphates.
Among the current diverse prodrug approaches, nucleoside phosphoramidate
derivatives appear to be an interesting class of antiviral and anticancer agents [1c].
These prodrugs, as are devoid of negative charge, should be able to cross the cell
membrane either by diffusion or utilizing transport protein [1c].
Conducted cell extract studies have provided evidence of a bioactivation
mechanism that relies on enzyme-catalyzed P-N bond hydrolysis in phosphoramidate
pronucleotides [1a,b]. It was assumed that phosphoramidate derivatives should
generate nucleoside monophosphates inside the cell at rates that are influenced by
both the nature of the amino group and the pH of the medium. Then nucleoside
monophosphates should be phosphorylated in two different steps to the corresponding
5’-O-triphosphates (NTP) which can inhibit polymerase or be incorporated
into the DNA strand being synthesized in the cell.
Over the last decade extensive studies has been carried out to establish the
mechanism of action of phosphoramidates and identification of enzymes responsible
for bioactivation this pronucleotides to phosphorylated nucleosides [7, 21, 24].
Investigation of metabolism pathways provided evidence that phosphoramidase
activity of Hint (histidine triad nucleotide-binding proteins) play a key role in the
activation of phosphoramidate pronucleotides [23–27].
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
Informacja
SZANOWNI CZYTELNICY!
UPRZEJMIE INFORMUJEMY, ŻE BIBLIOTEKA FUNKCJONUJE W NASTĘPUJĄCYCH GODZINACH:
Wypożyczalnia i Czytelnia Główna: poniedziałek – piątek od 9.00 do 19.00